University of California San Francisco
Give to UCSF
UCSF scientists have created a new class of highly customizable biological sensors that can be used to form “logic gates” inside cells of the immune system, giving these cells the capability to home in on and kill a wide range of cancer cells while preventing them from attacking normal tissue.
What if screening for cancer was as easy as checking your cholesterol? That’s the promise of techniques currently in development that may one day make it possible to detect the earliest stages of cancer with an annual blood draw.
Twice as many patients with non-serious injuries, such as fractures or neck strain, are undergoing CT scans in emergency departments at California hospitals, according to a UCSF-led study, which tracked the use of the imaging from 2005 to 2013.
We asked experts across UCSF to identify what's ahead in how we approach research, what disease areas will see major advances, and where basic science will be translating into real treatments.
The lineup is finalized for the 2016 Personalized Medicine World Conference, with nine scheduled talks by UCSF leaders and faculty.
The Cancer Center will give $250,000 to one high-risk, high-reward research project to address a key problem in cancer. Deadline for applications is Dec.18.
A new study by UCSF scientists shows that the proportion of normal cells, especially immune cells, intermixed with cancerous cells in a given tissue sample may significantly skew the results of genetic analyses and other tests performed both by researchers and by physicians selecting precision therapies.
UCSF researchers has discovered that single-celled yeast have sensory biases that can be hacked by a carefully engineered illusion, a finding that could be used to develop new approaches to fighting diseases such as cancer.
A study that tracked tens of thousands of midlife and older men for more than 20 years has found that vigorous exercise and other healthy lifestyle habits may cut their chances of developing a lethal type of prostate cancer by up to 68 percent.
UCSF researchers have found a human gene that could one day allow physicians to correct congenital deformities, regrow damaged fingers, or even mend a broken heart.
An international team of scientists led by UCSF researchers has mapped out the genetic trajectories taken by melanoma as it evolves from early skin lesions, known as precursors, to malignant skin cancer.
The UCSF Medal – the university’s highest honor – was awarded this year to philanthropist Helen Diller, School of Nursing dean emerita Kathleen Dracup, and Shirley M. Tilghman, president emerita at Princeton University.
Annual Institute for Human Genetic's symposium dedicated to recognition of Y.W.Kan's achievements.
UCSF has launched a collaboration with international pharmaceutical company GlaxoSmithKline plc (GSK) to promote early-stage research with the potential to translate into new therapies for cancer, obesity and antibiotic resistant bacteria.
A coalition of leukemia researchers led by scientists from UCSF has discovered surprising genetic diversity in juvenile myelomonocytic leukemia (JMML), a rare but aggressive childhood blood cancer.
Did you miss UC San Francisco at Dreamforce 2015? Watch some of the featured presentations.
Gay and bisexual men were up to six times more likely than heterosexual men to take part in indoor tanning, and twice as likely to report a history of skin cancer, according to a study led by UCSF researchers.
Online advertising based on Google search terms is a potentially effective way to deliver targeted cancer prevention education, according to a study led by Eleni Linos, MD, DrPH, assistant professor of dermatology at UCSF.
Adolescents and adults under 40 who have been successfully treated for cancer are at heightened risk of developing a second unrelated cancer, on average 15 years later, according to a study.
UCSF researchers have engineered a molecular “on switch” that allows tight control over the actions of T cells, immune system cells that have shown great potential as therapies for cancer.
UCSF scientists describe capturing and studying individual metastatic cells from human breast cancer tumors implanted into mice as the cells escaped into the blood stream and began to form tumors elsewhere in the body.
Zev Gartner is working to building a fully functioning 3-D human breast tissue that will allow him to test potential cancer therapies, an innovation that's earned him a spot among Popular Science's "Brilliant 10" this year.
